期刊
BIOMATERIALS SCIENCE
卷 8, 期 9, 页码 2376-2393出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/d0bm00129e
关键词
-
资金
- National Natural Science Foundation of China [8157010694]
- Free Exploration Project for Shenzhen [JCYJ20180307150419435]
- National Science and Technology Major Project of the Ministry of Science and Technology of China [2018ZX10301402]
- International Cooperation and Exchange of the National Natural Science Foundation of China [51820105004]
- Science and Technology Program of Guangzhou [201707010094, 201704020095]
- Guangdong Innovative and Entrepreneurial Research Team Program [2013S086, 2016ZT06S252, 2016ZT06S029]
- Science and Technology Planning Project of Shenzhen [JCYJ20170307141438157]
- Shenzhen Foundation of Science and Technology [JCYJ20170818103626421]
Hematological tumors are a group of diseases defined as the clonal proliferation of blood-forming cells. In recent years, incidences of hematological malignancies have increased. Traditional methods of diagnosing hematological tumors are primarily based on observing morphological features under light microscopy, and molecular diagnostics and immunological indicators are powerful auxiliary diagnostic methods. However, traditional methods cannot efficiently identify tumor markers and limit the efficiency and accuracy of diagnosis. Although treatment methods have been improved continuously, chemotherapy remains a primary technique for the treatment of hematological tumors. Traditional chemotherapy exhibits poor drug selectivity and lacks good biocompatibility and pharmacokinetic properties. The therapeutic effect is not ideal and the risk of toxic side effects is high. The nanosize and surface charge properties of nanodrugs are effective in improving drug delivery efficiency. The high load and rich surface modification methods of nanomaterials provide various possibilities for improving the biocompatibility and pharmacokinetics of drugs, as well as the targeting of drugs. In addition, a nanomedicine loading platform can load multiple drugs simultaneously and design the optimal proportion of combined drug schemes, which can improve the efficacy of drugs and reduce the occurrence of drug resistance. With their unique physical and chemical properties and biological characteristics, the application of nanoparticles in the diagnosis and treatment of hematological tumors has received considerable attention. In this review, we summarize recent advances in the application of various types of nanostructures for the diagnosis and treatment of hematological malignancies, investigate the advantages of nanomedicine compared with the traditional diagnosis and treatment of hematological tumors, and discuss their biological security and application prospects.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据